US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk

Hasan

New member
US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk US regulators have strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
 
Üst